Direxion Daily Biotech Top 5 Bull 2X ETFTBXU
Type
ETF
Peer group
Allocation
Net assets
$3.0M
Expense ratio
0.97%
1-year return
+75.2%
3 years, a year
—
5 years, a year
—
12-month yield
1.90%
Holdings
10
What it aims to do.
The Fund seeks daily investment results, before fees and expenses, of 200% of the daily performance of the Index. The Fund does not seek to achieve its stated investment objective for a period of time different than a trading day.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| Dreyfus Government Cash Manage | 30.03% |
| Goldman Financial | 25.55% |
| ARGX Argenx Se - Adr | 10.09% |
| REGN Regeneron Pharmaceuticals Inc | 8.55% |
| AMGN Amgen Inc. | 8.54% |
| VRTX Vertex Pharmaceuticals Inc | 8.22% |
| GILD Gilead Sciences Inc. | 8.14% |
| Goldman Sachs Liq Es Fd A | 5.42% |
| N/A | -1.51% |
| N/A | -4.67% |
More on TBXU.
- TBXU overview
- TBXU holdings
- TBXU risk
- TBXU costs
- TBXU money in and out
- TBXU share classes
- Compare TBXU with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.